AU2001271545A1 - Promoting whole body health - Google Patents

Promoting whole body health

Info

Publication number
AU2001271545A1
AU2001271545A1 AU2001271545A AU7154501A AU2001271545A1 AU 2001271545 A1 AU2001271545 A1 AU 2001271545A1 AU 2001271545 A AU2001271545 A AU 2001271545A AU 7154501 A AU7154501 A AU 7154501A AU 2001271545 A1 AU2001271545 A1 AU 2001271545A1
Authority
AU
Australia
Prior art keywords
whole body
body health
compositions
present
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271545A
Inventor
Matthew Joseph Doyle
Stephen Joseph Hunter-Rinderle
Robert Ernest Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24431416&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001271545(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2001271545A1 publication Critical patent/AU2001271545A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to promoting whole body health in humans and animals by using topical oral compositions comprising a safe and effective amount of an antimicrobial agent in admixture with a pharmaceutically acceptable carrier, said compositions being effective in controlling bacterial-mediated diseases and conditions present in the oral cavity and in inhibiting the spread into the bloodstream of pathogenic oral bacteria, associated bacterial toxins and endotoxins, and resultant inflammatory cytokines and mediators. The present invention also encompasses methods of use of these compositions by topically applying to the oral cavity, a safe and effective amount of an antimicrobial agent to promote and/or enhance whole body health in humans and other animals.
AU2001271545A 2000-06-30 2001-06-28 Promoting whole body health Abandoned AU2001271545A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60724000A 2000-06-30 2000-06-30
US09607240 2000-06-30
PCT/US2001/020516 WO2002002128A2 (en) 2000-06-30 2001-06-28 Oral compositions comprising antimicrobial agents

Publications (1)

Publication Number Publication Date
AU2001271545A1 true AU2001271545A1 (en) 2002-01-14

Family

ID=24431416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271545A Abandoned AU2001271545A1 (en) 2000-06-30 2001-06-28 Promoting whole body health

Country Status (14)

Country Link
US (3) US20050163727A1 (en)
EP (1) EP1294383B1 (en)
JP (2) JP2004517038A (en)
CN (1) CN1287803C (en)
AT (1) ATE401089T1 (en)
AU (1) AU2001271545A1 (en)
CA (1) CA2415068C (en)
DE (1) DE60134855D1 (en)
DK (1) DK1294383T3 (en)
ES (1) ES2309077T3 (en)
MX (1) MXPA03000041A (en)
PE (1) PE20020237A1 (en)
PT (1) PT1294383E (en)
WO (1) WO2002002128A2 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206874A1 (en) * 1996-11-21 2003-11-06 The Proctor & Gamble Company Promoting whole body health
DE60134855D1 (en) * 2000-06-30 2008-08-28 Procter & Gamble ORAL PREPARATIONS CONTAINING ANTIMICROBIAL ACTIVE SUBSTANCES FOR PREVENTING SYSTEMIC DISEASES
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US6652841B1 (en) * 2002-08-28 2003-11-25 Colgate Palmolive Company Antiplaque enzyme containing dual component composition
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
CN101947193B (en) 2003-12-16 2013-04-24 高露洁-棕榄公司 Oral and personal care compositions and methods
US8628690B2 (en) * 2004-02-23 2014-01-14 The Texas A&M University System Nanoemulsion compositions and methods of use thereof
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
EP1671623A1 (en) * 2004-10-01 2006-06-21 Giuseppe Vrespa Composition for use in the antibacterial and antiinflammatory treatment of the oral cavity
DE102004052308B4 (en) * 2004-10-12 2013-04-04 Divapharma-Knufinke Arzneimittelwerk Gmbh Octenidine-containing lozenges against inflammatory diseases of the mouth and throat
US8974772B2 (en) 2004-12-28 2015-03-10 Colgate-Palmolive Company Two phase toothpaste composition
DE102005002644A1 (en) * 2005-01-19 2006-07-20 Schülke & Mayr GmbH Compositions for hygienic hand disinfection and disinfecting hand washing
JP5024505B2 (en) * 2005-03-25 2012-09-12 ライオン株式会社 Remedy for hyperlipidemia caused by periodontal disease, oral composition and oral medicine
US20060243298A1 (en) * 2005-04-28 2006-11-02 The Procter & Gamble Company Dental floss compositions comprising menthol and carboxamides
DE102005058978A1 (en) * 2005-08-26 2007-03-29 Bode Chemie Gmbh & Co. Kg Wound and mucous membrane disinfectant
DE102005045145A1 (en) 2005-09-15 2007-03-29 Schülke & Mayr GmbH Use of octenidine dihydrochloride in semisolid preparations
CN100356902C (en) * 2005-09-21 2007-12-26 美晨集团股份有限公司 Toothpaste containing anion and cation surface activator and production thereof
WO2007052436A1 (en) * 2005-10-31 2007-05-10 Niigata University Microcapsule and method of producing the same
ES2606342T3 (en) 2005-11-23 2017-03-23 Colgate-Palmolive Company Compositions for oral care of stannous salt and sodium tripoli phosphate and methods
US20070254260A1 (en) * 2005-12-02 2007-11-01 Alden Wayne S Iv Oral care compositions, methods, devices and systems
GB0600431D0 (en) * 2006-01-10 2006-02-15 Sinclair Pharmaceuticals Ltd Method
GB0604018D0 (en) 2006-02-28 2006-04-05 Sinclair Pharmaceuticals Ltd Method
WO2007099060A2 (en) * 2006-03-02 2007-09-07 Unilever N.V. Dual phase abrasive toothpaste composition
EP2001450B1 (en) * 2006-03-31 2019-01-30 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
JP2009533344A (en) * 2006-04-07 2009-09-17 ザ プロクター アンド ギャンブル カンパニー Oral care plan and kit
CA2653390C (en) 2006-06-02 2014-07-08 Hawaii Chitopure, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
WO2008021088A2 (en) * 2006-08-08 2008-02-21 The Regents Of The University Of Californina Salicylanilides enhance oral delivery of therapeutic peptides
DE102006051891A1 (en) 2006-10-31 2008-05-08 Schülke & Mayr GmbH Antimicrobial composition containing Bispyridiniumalkan
ES2442253T3 (en) * 2007-02-23 2014-02-10 The Procter & Gamble Company Oral Polyphosphate Compositions
DE102007028184A1 (en) 2007-06-20 2008-12-24 Braun Gmbh Brush head for a toothbrush
US20090151649A1 (en) * 2007-12-14 2009-06-18 Summit Applied Technologies, Inc. Chewable animal toy
US20090188521A1 (en) * 2008-01-17 2009-07-30 Evazynajad Ali M Dental Floss Formed from Botanic and Botanically Derived Fiber
DE102008011691A1 (en) 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilized antimicrobial composition containing bispyridiniumalkane
NZ593892A (en) 2008-12-23 2013-11-29 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
KR100935211B1 (en) 2008-12-30 2010-01-06 남지원 Composition of toothpowder-paste containing wheat-flour and bamboo-salt, and manufacturing method thereof
RU2517136C2 (en) * 2009-04-02 2014-05-27 Колгейт-Палмолив Компани Peeling composition for teeth cleaning and method of its application
JP2013503897A (en) * 2009-09-02 2013-02-04 シネジェン， インコーポレイテッド Oral care method and composition using chitosan derivative compound
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
GB2481630A (en) * 2010-07-01 2012-01-04 Robert Taylor Composition for dental health
BR112013003081B1 (en) 2010-08-07 2022-02-01 The Research Foundation For The State University Of New York Oral compositions comprising a zinc compound and an antimicrobial agent
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
EP2648705B1 (en) 2010-12-07 2016-11-16 Colgate-Palmolive Company Oral care compositions comprising a quinone and a further antimicrobial agent
US10426761B2 (en) * 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
US8731747B2 (en) 2011-04-28 2014-05-20 General Electric Company Communication systems and method for a rail vehicle or other powered system
US8620552B2 (en) 2011-06-13 2013-12-31 General Electric Company Data communication system and method for communicating data in a vehicle
US8798807B2 (en) 2011-06-13 2014-08-05 General Electric Company Data distribution system and method for distributing data in a vehicle
US8510026B2 (en) 2011-06-13 2013-08-13 General Electric Company Data conversion system and method for converting data that is distributed in a vehicle
JP5735898B2 (en) * 2011-10-18 2015-06-17 東亜薬品株式会社 Liquid composition for gargle
WO2014098865A1 (en) 2012-12-20 2014-06-26 Hill's Pet Nutrition, Inc. Pattern recognition receptor expression as a measure of systemic health
CA2905404C (en) 2013-03-12 2021-07-20 Synedgen, Inc. Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar
CN104628097B (en) * 2013-11-11 2016-08-10 中国石油化工股份有限公司 A kind of disinfecting corrosion inhibitor compositions and application thereof
CN108472209B (en) 2015-12-30 2021-06-25 高露洁-棕榄公司 Personal care compositions
CN109069391B (en) 2015-12-30 2022-02-11 高露洁-棕榄公司 Oral care compositions
CN108463208B (en) 2015-12-30 2021-12-07 高露洁-棕榄公司 Oral care compositions
EP3380064B1 (en) 2015-12-30 2020-05-06 Colgate-Palmolive Company Personal care compositions
CN106176546A (en) * 2016-08-26 2016-12-07 湖北立天生物工程有限公司 Based on the cleaning of the chitosan derivatives degree of depth, bacteriostatic tooth protective collutory and preparation method thereof
CA3072739A1 (en) * 2017-08-15 2019-02-21 Sanford L.P. Glue slime activator and associated methods and kits
US10738175B2 (en) * 2017-08-15 2020-08-11 Sanford, L.P. Glue slime activator and associated methods and kits
WO2020005841A1 (en) 2018-06-25 2020-01-02 Triumph Pharmaceuticals Inc. Methods of inhibiting microbial infections using zinc-containing compositions
US20210161785A1 (en) * 2018-08-10 2021-06-03 Chx Technologies, Inc. Method of Preventing Both Caries and Periodontal Disease Simultaneously in One Procedure
US11033485B1 (en) * 2019-05-16 2021-06-15 Shear Kershman Laboratories, Inc. Dental care system containing anti-tartar and anti-plaque actives
WO2022053194A1 (en) * 2020-09-08 2022-03-17 Unilever Ip Holdings B.V. Oral care compositions

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946725A (en) * 1957-03-25 1960-07-26 Procter & Gamble Dentifrice compositions
US4051234A (en) * 1975-06-06 1977-09-27 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4206215A (en) * 1976-02-25 1980-06-03 Sterling Drug Inc. Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes
US4599228A (en) * 1981-01-19 1986-07-08 Vipont Laboratories, Inc. Antimicrobial agent
JPH0627058B2 (en) * 1986-12-04 1994-04-13 ライオン株式会社 Toothpaste composition
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5004597A (en) * 1987-09-14 1991-04-02 The Procter & Gamble Company Oral compositions comprising stannous flouride and stannous gluconate
US4902498A (en) * 1988-06-01 1990-02-20 The Procter & Gamble Company Oral compositions
US5334375A (en) * 1988-12-29 1994-08-02 Colgate Palmolive Company Antibacterial antiplaque oral composition
JPH0768109B2 (en) * 1989-01-10 1995-07-26 株式会社オブジェ科学研究所 Toothpaste composition
DE3925540C1 (en) 1989-08-02 1990-08-30 Schuelke & Mayr Gmbh, 2000 Norderstedt, De
US5198220A (en) * 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5015466A (en) * 1990-06-26 1991-05-14 The Procter & Gamble Company Anticalculus compositions using tartrate-succinates
US5154917A (en) * 1990-09-11 1992-10-13 Beecham Inc. Color change mouthrinse
JP3157563B2 (en) * 1991-10-29 2001-04-16 株式会社サンギ Toothpaste
US5356615A (en) * 1991-01-30 1994-10-18 Colgate Palmolive Company Antiplaque oral compositions
GB9110721D0 (en) * 1991-05-17 1991-07-10 Unilever Plc Dentifrice compositions
GB9117315D0 (en) * 1991-08-09 1991-09-25 Unilever Plc Method of controlling dental tartar and compositions for use therein
JPH05163125A (en) * 1991-12-13 1993-06-29 Shinagawa Fuel Co Ltd Composition for oral cavity
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5830511A (en) * 1992-06-25 1998-11-03 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
US6004587A (en) * 1992-06-25 1999-12-21 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
WO1994014407A1 (en) * 1992-12-18 1994-07-07 The Procter & Gamble Company Oral compositions containing antiplaque, anticalculus agents
US5578293A (en) * 1994-12-06 1996-11-26 Colgate Palmolive Company Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5672598A (en) * 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
WO1997047292A1 (en) * 1996-06-12 1997-12-18 The Procter & Gamble Company Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
GB2317339A (en) * 1996-08-01 1998-03-25 Procter & Gamble Dentifrice composition containing a curcuminoid
US5753217A (en) * 1996-08-14 1998-05-19 William C. Christopfel Method of reducing oral malodor
ATE272062T1 (en) * 1996-08-28 2004-08-15 Procter & Gamble SPIROCYCLIC METALLOPROTEASE INHIBITORS
JP3539736B2 (en) * 1996-08-28 2004-07-07 ザ プロクター アンド ギャンブル カンパニー Phosphinamides as substrate metalloprotease inhibitors
US5939052A (en) * 1996-11-21 1999-08-17 The Procter & Gamble Company Dentifrice compositions containing polyphosphate and fluoride
US6187295B1 (en) * 1996-11-21 2001-02-13 The Procter & Gamble Company Methods of reducing the astringency of stannous in dentifrice compositions
AU7191898A (en) * 1997-06-25 1999-01-07 Mcneil-Ppc, Inc. Tartar control dental floss
US5875799A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic dental floss for treating systemic diseases
US5875798A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
US6846478B1 (en) * 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
JP2003517442A (en) * 1998-09-23 2003-05-27 ユニリーバー・ナームローゼ・ベンノートシヤープ Oral care composition
JP2002531387A (en) * 1998-11-30 2002-09-24 ザ、プロクター、エンド、ギャンブル、カンパニー Method for reducing priming tin in toothpaste compositions
DE60134855D1 (en) * 2000-06-30 2008-08-28 Procter & Gamble ORAL PREPARATIONS CONTAINING ANTIMICROBIAL ACTIVE SUBSTANCES FOR PREVENTING SYSTEMIC DISEASES

Also Published As

Publication number Publication date
MXPA03000041A (en) 2003-10-15
PT1294383E (en) 2008-10-08
DK1294383T3 (en) 2008-11-10
CA2415068C (en) 2009-03-10
WO2002002128A3 (en) 2002-04-25
CN1287803C (en) 2006-12-06
WO2002002128A2 (en) 2002-01-10
DE60134855D1 (en) 2008-08-28
ATE401089T1 (en) 2008-08-15
EP1294383B1 (en) 2008-07-16
CA2415068A1 (en) 2002-01-10
ES2309077T3 (en) 2008-12-16
EP1294383A2 (en) 2003-03-26
JP2004517038A (en) 2004-06-10
PE20020237A1 (en) 2002-04-18
CN1522149A (en) 2004-08-18
JP2008143910A (en) 2008-06-26
US20070140987A1 (en) 2007-06-21
US20050163727A1 (en) 2005-07-28
US20110306018A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
AU2001271545A1 (en) Promoting whole body health
WO2002002063A3 (en) Promoting whole body health
WO2001045679A3 (en) Use of chemotherapeutic agents for topical treatment
CA2415065A1 (en) Oral compositions comprising host-response modulating agent
MY157928A (en) Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
FI963232A0 (en) Acidified nitrite as an antimicrobial agent
WO2000010582A3 (en) Probiotic, lactic acid-producing bacteria and uses thereof
MXPA05006685A (en) Antibiotics containing borinic acid complexes and methods of use.
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
PT806941E (en) LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY
HRP20090022T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
ATE390124T1 (en) TREATMENT OF MASTITIS WITH A COMBINATION OF PREDNISOLONE AND CEPHALOSPORIN
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
SE0004101D0 (en) New use
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
PL345452A1 (en) Chemotaxis-inhibiting protein of staphylococcus
WO2004093876A3 (en) Composition containing berberine or a derivative thereof and an antimicrobial agent or an antibiotic agent, and their use for treating oral pathogens and other disorders
WO2003024996A3 (en) Antibacterial macrocycles
DE60214889D1 (en) Sucroseoctasulphat silber saltz
WO2024147763A3 (en) Antimicrobial conjugated oligoelectrolytes and methods thereof
WO2002076483A3 (en) Bacteriophage preparation
WO2000041473A3 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
HUP0203876A2 (en) Pharmaceutical combinations for topical application
MX9603535A (en) Acidified nitrite as an antimicrobial agent.